News
The US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use ...
Biogen’s first quarter results outpaced Wall Street’s expectations, prompting a positive market reaction. Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback